Sebastian Fain > Freshfields Bruckhaus Deringer LLP > New York, United States > Lawyer Profile
Freshfields Bruckhaus Deringer LLP Offices
601 LEXINGTON AVENUE
31ST FLOOR
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Sebastian Fain
Position
Partner
Career
Sebastian focuses on M&A, activism defense and corporate governance. His experience is centered on domestic and cross-border M&A, including public company mergers and de-SPAC transactions, private equity acquisitions, joint ventures, complex business carve-outs and divestitures, hostile takeovers and defense, carve-out IPOs, spin-offs and split-offs. He also has experience representing clients in complex commercial agreements and in capital markets transactions, such as IPOs, secondary offerings, block trades, high-yield bond offerings and exchange offers.
In addition, Sebastian extensively counsels management and boards of directors on governance, activism and disclosure matters.
Education
- JD, Harvard Law School
- AB in Biology, Harvard University
- Admitted to practice in the State of New York
Lawyer Rankings
United States > M&A/corporate and commercial > M&A: large deals ($1bn+)
(Next Generation Partners)Acting for the likes of international pharma corporations, tech providers, and energy conglomerates, the Freshfields Bruckhaus Deringer LLP team comprises a set of corporate specialists who cover matters ranging from cross-border transactions to takeover defense. Ethan Klingsberg and Damien Zoubek co-head the New York offering, with the former routinely advising special committees and boards of directors on impactful mergers and complex governance issues, while the latter is an expert on shareholder activism defense. Also in New York, Jenny Hochenberg frequently tackles transformative M&A transactions, Sebastian Fain is knowledgeable on joint ventures, and both Paul Tiger and Paul Humphreys focus on stockholder activism and all-stock mergers. Based in San Francisco, John Fisher has expertise in the life sciences sector, while Joseph Halloum concentrates on IPOs and SPAC transactions.
United States > M&A/corporate and commercial > Shareholder activism
The New York-based team at Freshfields Bruckhaus Deringer LLP has broad experience across all aspects of shareholder activism defense and preparation, from negotiations and settlement agreements, to poison pills and navigating wolf packs. Department co-head Elizabeth Bieber focuses her practice on activism and takeover defense preparedness and corporate governance matters. Leading the team alongside her is Ethan Klingsberg, who also co-heads the firm’s broader corporate and M&A offering. Damien Zoubek is familiar with shareholder activism defense scenarios across different industries, and Sebastian Fain is another key contact who regularly counsels management and boards of directors.
Lawyer Rankings
- Next Generation Partners United States > M&A/corporate and commercial > M&A: large deals ($1bn+)
- M&A: large deals ($1bn+) United States > M&A/corporate and commercial
- Shareholder activism United States > M&A/corporate and commercial
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Dispute resolution > International arbitration
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Tax > Financial products
Firm Rankings
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- International trade > CFIUS
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > General commercial disputes
- Media, technology and telecoms > Technology transactions
- Healthcare > Life sciences
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism